Melanocortin receptors as targets in the treatment of obesity

Current Topics in Medicinal Chemistry

Volumn 7, Issue 11, 2007, Pages 1098-1110

  Lam, Daniel D ^a   Farooqi, I Sadaf ^a   Heisler, Lora K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Energy expenditure; Food intake; MC4R; Melanocortin; Obesity

Indexed keywords

AGOUTI PROTEIN; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; BETA INTERMEDIN; CHOLECYSTOKININ; CORTICOTROPIN[4-10]; GAMMA INTERMEDIN; GHRELIN; HORMONE DERIVATIVE; HORMONE RECEPTOR AFFECTING AGENT; INSULIN; LEPTIN; LIGAND; MELANOCORTIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR ANTAGONIST; MELANOCORTIN DERIVATIVE; MELANOCORTIN RECEPTOR; MELANOTAN II; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE Y; OREXIN; PLACEBO; PROOPIOMELANOCORTIN; RO 27 3225; SEROTONIN; TETRAHYDROISOQUINOLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARCUATE NUCLEUS; BODY WEIGHT; BRAIN NERVE CELL; BRAIN STEM; CLINICAL TRIAL; DRUG DESIGN; DRUG DISTRIBUTION; DRUG TARGETING; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPOTHALAMUS; MUTATION; NERVE CELL; NONHUMAN; NUTRITION; OBESITY; REGULATORY MECHANISM; REVIEW; SOLITARY TRACT NUCLEUS;

EID: 34447291639     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607780906564     Document Type: Review

References (196)

1. Pritchard, L.E.; Turnbull, A.V.; White, A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 2002, 172, 411-21.
2. Miller, M.W.; Duhl, D.M.; Vrieling, H.; Cordes, S.P.; Ollmann, M.M.; Winkes, B.M.; Barsh, G.S. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 1993, 7, 454-67.
3. Lu, D.; Willard, D.; Patel, I.R.; Kadwell, S.; Overton, L.; Kost, T.; Luther, M.; Chen, W.; Woychik, R.P.; Wilkison, W.O.; Cone, R.D. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371, 799-802.
4. Shutter, J.R.; Graham, M.; Kinsey, A.C.; Scully, S.; Luthy, R.; Stark, K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 1997, 11, 593-602.
5. Ollmann, M.M.; Wilson, B.D.; Yang, Y.K.; Kerns, J.A.; Chen, Y.; Gantz, I.; Barsh, G.S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997, 278, 135-8.
6. Haskell-Luevano, C.; Monck, E.K. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regul. Pept. 2001, 99, 1-7.
7. Nijenhuis, W.A.; Oosterom, J.; Adan, RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol. Endocrinol. 2001, 15, 164-71.
8. Siegrist, W.; Drozdz, R.; Cotti, R.; Willard, D.H.; Wilkison, W.O.; Eberle, A.N. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J. Recept. Signal. Transduct. Res. 1997, 17, 75-98.
9. Robbins, L.S.; Nadeau, J.H.; Johnson, K.R.; Kelly, M.A.; Roselli-Rehfuss, L.; Baack, E.; Mountjoy, K.G.; Cone, R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993, 72, 827-34.
10. Clark, A.J.; McLoughlin, L.; Grossman, A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993, 341, 461-2.
11. Chen, W.; Kelly, M.A.; Opitz-Araya, X.; Thomas, R.E.; Low, M.J.; Cone, R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin Pept. Cell 1997, 91, 789-98.
12. Cone, R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 8(5), 571-8.
13. Panskepp, J.; Reilly, P.; Bishop, P.; Meeker, R.B.; Vilberg, T.R.; Kastin, A.J. Effects of alpha-MSH on motivation, vigilance and brain respiration. Pharmacol. Biochem. Behav. 1976, 5, 59-64.
14. Challis, B.G.; Coll, A.P.; Yeo, G.S.; Pinnock.; S.B.; Dickson.; S.L.; Thresher, R.R.; Dixon.; J.; Zhan.; D.; Rochford.; J.J.; White.; A.; Oliver.; R.L.; Millington.; G.; Aparicio.; S.A.; Colledge.; W.H.; Russ.; A.P.; Carlton.; M.B.; O'Rahilly.; S. Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY)3-36). Proc. Natl. Acad. Sci. USA. 2004, 101, 4695-700.
15. Yaswen, L.; Diehl, N.; Brennan, M.B.; Hochgeschwender, U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 1999, 5, 1066-70.
16. Gropp, E.; Shanabrough, M.; Borok, E.; Xu, A.W.; Janoschek, R.; Buch, T.; Plum, L.; Balthasar, N.; Hampel, B.; Waisman, A.; Barsh, G.S.; Horvath, T.L.; Bruning, J.C. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 2005, 8, 1289-91.
17. Naggert, J.K.; Fricker, L.D.; Varlamov, O.; Nishina, P.M.; Rouille, Y.; Steiner, D.F.; Carroll, R.J.; Paigen, B.J.; Leiter, E.H. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 1995, 10, 135-42.
18. Bewick, G.A.; Gardiner, J.V.; Dhillo, W.S.; Kent, A.S.; White, NE.; Webster, Z.; Ghatei, M.A.; Bloom, S.R. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 2005, 19, 1680-2.
19. Luquet, S.; Perez, F.A.; Hnasko, T.S.; Palmiter, R.D. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005, 310, 683-5.
20. Qian, S.; Chen, H.; Weingarth, D.; Trumbauer, M.E.; Novi, D.E.; Guan, X.; Yu, H.; Shen, Z.; Feng, Y.; Frazier, E.; Chen, A.; Camacho, R.E.; Shearman, L.P.; Gopal-Truter, S.; MacNeil, D.J.; Van, der, Ploeg, LH.; Marsh, D.J. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell Biol. 2002, 22, 5027-35.
21. Huszar, D.; Lynch, C.A.; Fairchild-Huntress, V.; Dunmore, J.H.; Fang, Q.; Berkemeier, L.R.; Gu, W.; Kesterson, R.A.; Boston, B.A.; Cone, R.D.; Smith, F.J.; Campfield, L.A.; Burn, P.; Lee, F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88, 131-41.
22. Ste, Marie, L.; Miura, G.I.; Marsh, D.J.; Yagaloff, K.; Palmiter, RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. USA 2000, 97, 12339-44.
23. Marsh, D.J.; Hollopeter, G.; Huszar, D.; Laufer, R.; Yagaloff, K.A.; Fisher, S.L.; Burn, P.; Palmiter, RD. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic Peptides Nat. Genet. 1999, 21, 119-22.
24. Butler, A.A.; Kesterson, R.A.; Khong, K.; Cullen, M.J.; Pelleymounter, M.A.; Dekoning, J.; Baetscher, M.; Cone, R.D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141, 3518-21.
25. Chen, A.S.; Marsh, D.J.; Trumbauer, M.E.; Frazier, E.G.; Guan, X.M.; Yu, H.; Rosenblum, C.I.; Vongs, A.; Feng, Y.; Cao, L.; Metzger, J.M.; Strack, A.M.; Camacho, R.E.; Mellin, T.N.; Nunes, C.N.; Min, W.; Fisher, J.; Gopal-Truter, S.; MacIntyre, D.E.; Chen, H.Y.; Van, der, Ploeg, L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000, 26, 97-102.
26. Krude, H.; Biebermann, H.; Luck, W.; Horn, R.; Brabant, G.; Gruters, A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998, 19, 155-7.
27. Jackson, R.S.; Creemers, J.W.; Ohagi, S.; Raffin-Sanson, M.L.; Sanders, L.; Montague, C.T.; Hutton, J.C.; O'Rahilly, S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 1997, 16, 303-6.
28. Farooqi, I.S.; Yeo, G.S.; Keogh, J.M.; Aminian, S.; Jebb, S.A.; Butler, G.; Cheetham, T.; O'Rahilly, S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 2000, 106, 271-9.
29. Gu, W.; Tu, Z.; Kleyn, P.W.; Kissebah, A.; Duprat, L.; Lee, J.; Chin, W.; Maruti, S.; Deng, N.; Fisher, S.L.; Franco, L.S.; Burn, P.; Yagaloff, K.A.; Nathan, J.; Heymsfield, S.; Albu, J.; Pi-Sunyer, F.X.; Allison, D.B. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999, 48, 635-9.
30. Hinney, A.; Schmidt, A.; Nottebom, K.; Heibult, O.; Becker, I.; Ziegler, A.; Gerber, G.; Sina, M.; Gorg, T.; Mayer, H.; Siegfried, W.; Fichter, M.; Remschmidt, H.; Hebebrand, J. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 1999, 84, 1483-6.
31. Sina, M.; Hinney, A.; Ziegler, A.; Neupert, T.; Mayer, H.; Siegfried, W.; Blum, W.F.; Remschmidt, H.; Hebebrand, J. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am. J. Hum. Genet. 1999, 65, 1501-7.
32. Vaisse, C.; Clement, K.; Guy-Grand, B.; Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 1998, 20, 113-4.
33. Yeo; G.S.; Farooqi, I.S.; Aminian, S.; Halsall, D.J.; Stanhope, R.G.; O'Rahilly, S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 1998, 20, 111-2.
34. Farooqi, I.S.; Keogh, J.M.; Yeo, G.S.; Lank, E.J.; Cheetham, T.; O'Rahilly, S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 2003, 348, 1085-95.
35. Palkovits, M.; Mezey, E.; Eskay, RL. Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res. 1987, 436, 323-38.
36. Bronstein, D.M.; Schafer, M.K.; Watson, S.J.; Akil, H. Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA. Brain Res. 1992, 587, 269-75.
37. Broberger, C.; Johansen, J.; Johansson, C.; Schalling, M.; Hokfelt, T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 1998, 95(25), 15043-8.
38. Elias, C.F.; Saper, C.B.; Maratos-Flier, E.; Tritos, N.A.; Lee, C.; Kelly, J.; Tatro, J.B.; Hoffman, G.E.; Ollmann, M.M.; Barsh, G.S.; Sakurai, T.; Yanagisawa, M.; Elmquist, JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 402(4), 442-59.
39. Bagnol, D.; Lu, X.Y.; Kaelin, C.B.; Day, H.E.; Ollmann, M.; Gantz, I.; Akil, H.; Barsh, G.S.; Watson, S.J. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 1999, 19(18), 26.
40. Cowley, M.A.; Smart, J.L.; Rubinstein, M.; Cerdan, M.G.; Diano, S.; Horvath, T.L.; Cone, R.D.; Low, M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411(6836), 480-4.
41. Roseberry, A.G.; Liu, H.; Jackson, A.C.; Cai, X.; Friedman, J.M. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004, 41(5), 711-22.
42. Brady, L.S.; Smith, M.A.; Gold, P.W.; Herkenham, M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 1990, 52(5), 441-7.
43. Huo, L.; Grill, H.J.; Bjorbaek, C. Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes 2006, 55(3), 567-73.
44. Mizuno, T.M.; Kleopoulos, S.P.; Bergen, H.T.; Roberts, J.L.; Priest, C.A.; Mobbs, C.V. Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998, 47(2), 294-7.
45. Hoggard, N.; Hunter, L.; Duncan, J.S.; Rayner, D.V. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system. J. Mol. Endocrinol. 2004, 32(1), 145-53.
46. Hagan, M.M.; Rushing, P.A.; Schwartz, M.W.; Yagaloff, K.A.; Burn, P.; Woods, S.C.; Seeley, R.J. Role of the CNS melanocortin system in the response to overfeeding. J. Neurosci. 1999, 19(6), 2362-7.
47. Mizuno, T.M.; Mobbs, C.V. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 1999, 140(2), 814-7.
48. Wilson, B.D.; Bagnol, D.; Kaelin, C.B.; Ollmann, M.M.; Gantz, I.; Watson, S.J.; Barsh, G.S. Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology 1999, 140(5), 2387-97.
49. Li, J.Y.; Finniss, S.; Yang, Y.K.; Zeng, Q.; Qu, S.Y.; Barsh, G.; Dickinson, C.; Gantz, I. Agouti-related protein-like immunoreactivity: characterization of release from hypothalamic tissue and presence in serum. Endocrinology 2000, 141(6), 1942-50.
50. Ziotopoulou, M.; Mantzoros, C.S.; Hileman, S.M.; Flier, J.S. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am. J. Physiol. Endocrinol. Metab. 2000, 279(4), 838-45.
51. Ibrahim, N.; Bosch, M.A.; Smart, J.L.; Qiu, J.; Rubinstein, M.; Ronnekleiv, O.K.; Low, M.J.; Kelly, M.J. Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels. Endocrinology 2003, 144(4), 1331-40.
52. Frederich, R.C.; Lollmann, B.; Hamann, A.; Napolitano-Rosen, A.; Kahn, B.B.; Lowell, B.B.; Flier, J.S. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 1995, 96(3), 658-63.
53. Friedman, J.M.; Halaas, J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395(6704), 763-70.
54. Schwartz, M.W.; Seeley, R.J.; Campfield, L.A.; Burn, P.; Baskin, D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 1996, 98(5), 1101-6.
55. Cheung, C.C.; Clifton, D.K.; Steiner, R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997, 138(10), 4489-92.
56. Elias, C.F.; Aschkenasi, C.; Lee, C.; Kelly, J.; Ahima, R.S.; Bjorbaek, C.; Flier, J.S.; Saper, C.B.; Elmquist, J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 23(4), 775-86.
57. Schwartz, M.W.; Seeley, R.J.; Woods, S.C.; Weigle, D.S.; Campfield, L.A.; Burn, P.; Baskin, D.G. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997, 46(12), 2119-23.
58. Thornton, J.E.; Cheung, C.C.; Clifton, D.K.; Steiner, R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997, 138(11), 5063-6.
59. Ahima, R.S.; Kelly, J.; Elmquist, J.K.; Flier, J.S. Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 1999, 140(11), 4923-31.
60. Ellacott, K.L.; Halatchev, I.G.; Cone, R.D. Characterization of leptin-responsive neurons in the caudal brainstem. Endocrinology 2006, 147(7), 3190-5.
61. Seeley, R.J.; Yagaloff, K.A.; Fisher, S.L.; Burn, P.; Thiele, T.E.; van, Dijk, G.; Baskin, D.G.; Schwartz, M.W. Melanocortin receptors in leptin effects. Nature 1997, 390(6658), 349.
62. Kask A.; Rago, L.; Wikberg, J.E.; Schioth, H.B. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur. J. Pharmacol. 1998, 360(1), 15-9.
63. Halaas, J.L.; Boozer, C.; Blair-West, J.; Fidahusein, N.; Denton, D.A.; Friedman, J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 1997, 94(16), 8878-83.
64. Satoh, N.; Ogawa, Y.; Katsuura, G.; Numata, Y.; Masuzaki, H.; Yoshimasa, Y.; Nakao, K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci. Lett. 1998, 249(2-3), 107-10.
65. Norman, D.; Isidori, A.M.; Frajese, V.; Caprio, M.; Chew, S.L.; Grossman, A.B.; Clark, A.J.; Michael, Besser, G.; Fabbri, A. ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Mol. Cell Endocrinol. 2003, 200(1-2), 99-109.
66. Halford, J.C.; Blundell, J.E. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence. Physiol. Behav. 1996, 60(3), 933-9.
67. Hewitt, K.N.; Lee, M.D.; Dourish, C.T.; Clifton, P.G. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol. Biochem. Behav. 2002, 71(4), 691-700.
68. Lee, M.D.; Simansky, K.J. CP-94,253: a selective serotonin1B (5-HT1B) agonist that promotes satiety. Psychopharmacology (Berl). 1997, 131(3), 264-70.
69. Kennett, G.A.; Curzon, G. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl). 1988, 96(1), 93-100.
70. Koe, B.K.; Nielsen, J.A.; Macor, J.E.; Heym, J. Biochemical and behavioural studies of the 5-HTtB receptor agonist CP-94,253. Drug Dev. Res. 1992, 26, 241-250.
71. Heisler, L.K.; Cowley, M.A.; Tecott, L.H.; Fan, W.; Low, M.J.; Smart, J.L.; Rubinstein, M.; Tatro, J.B.; Marcus, J.N.; Holstege, H.; Lee, C.E.; Cone, R.D.; Elmquist, J.K. Activation of central melanocortin pathways by fenfluramine. Science 2002, 297(5581), 609-11.
72. Heisler, L.K.; Jobst E.E.; Sutton, G.M.; Zhou, L.; Borok, E.; Thornton-Jones, Z.; Liu, H.Y.; Zigman, J.M.; Balthasar, N.; Kishi, T.; Lee, C.E.; Aschkenasi, C.J.; Zhang, C.Y.; Yu, J.; Boss, O.; Mountjoy, K.G.; Clifton, P.G.; Lowell, B.B.; Friedman, J.M.; Horvath, T.; Butler, A.A.; Elmquist J.K.; Cowley, M.A. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 2006, 51(2), 239-49.
73. Kim, E.M.; Grace, M.K.; Welch, C.C.; Billington, C.J.; Levine, A.S. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 1992, 276, 1320-6.
74. Fan, W.; Ellacott, K.L.; Halatchev, I.G.; Takahashi, K.; Yu, P.; Cone, R.D. Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nat. Neurosci. 2004, 7(4), 335-6.
75. Hahn, T.M.; Breininger, J.F.; Baskin, D.G.; Schwartz, M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1998, 1(4), 271-2.
76. Clark, J.T.; Kalra, P.S.; Crowley, W.R.; Kalra, SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984, 115(1), 427-9.
77. Billington, C.J.; Briggs, J.E.; Grace, M.; Levine, A.S. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am. J. Physiol. 1991, 260(2 2), 321-7.
78. Calza, L.; Giardino, L.; Battistini, N.; Zanni, M.; Galetti, S.; Protopapa, F.; Velardo, A. Increase of neuropeptide Y-like immunoreactivity in the paraventricular nucleus of fasting rats. Neurosci. Lett. 1989, 104(1-2), 99-104.
79. Sanacora, G.; Kershaw, M.; Finkelstein, J.A.; White, J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990, 127(2), 730-7.
80. Blasquez, C.; Jegou, S.; Friard, O.; Tonon, M.C.; Fournier, A.; Vaudry, H. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat. Neuroscience 1995, 68(1), 221-7.
81. Danger, JM.; Tonon, M.C.; Lamacz, M.; Martel, J.C.; Saint-Pierre, S.; Pelletier, G.; Vaudry, H. Melanotropin release inhibiting activity of neuropeptide Y: structure-activity relationships. Life Sci. 1987, 40(19), 1875-80.
82. Garcia, de, Yebenes, E.; Li, S.; Fournier, A.; St-Pierre, S.; Pelletier, G. Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res. 1995, 674(1), 112-6.
83. Cowley, M.A.; Smith, R.G.; Diano, S.; Tschop, M.; Pronchuk, N.; Grove, K.L.; Strasburger, C.J.; Bidlingmaier, M.; Esterman, M.; Heiman, M.L.; Garcia-Segura, L.M.; Nillni, E.A.; Mendez, P.; Low, M.J.; Sotonyi, P.; Friedman, J.M.; Liu, H.; Pinto, S.; Colmers, W.F.; Cone, R.D.; Horvath, T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37(4), 649-61.
84. Tschop, M.; Smiley, D.L.; Heiman, M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806), 908-13.
85. Cummings, D.E.; Purnell, J.Q.; Frayo, R.S.; Schmidova, K.; Wisse, B.E.; Weigle, D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50(8), 1714-9.
86. Kamegai, J.; Tamura, H.; Shimizu, T.; Ishii, S.; Sugihara, H.; Wakabayashi, I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141(12), 4797-800.
87. Dickson, S.L.; Luckman, S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997, 138(2), 771-7.
88. Wang, L.; Saint-Pierre, D.H.; Tache, Y. Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci. Lett. 2002, 325(1), 47-51.
89. Sakurai, T.; Amemiya, A.; Ishii, M.; Matsuzaki, I.; Chemelli, R.M.; Tanaka, H.; Williams, S.C.; Richardson, J.A.; Kozlowski, G.P.; Wilson, S.; Arch, J.R.; Buckingham, R.E.; Haynes, A.C.; Carr, S.A.; Annan, R.S.; McNulty, D.E.; Liu, W.S.; Terrett, J.A.; Elshourbagy, N.A.; Bergsma, D.J.; Yanagisawa, M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(4), 573-85.
90. Kurose, T.; Ueta, Y.; Yamamoto, Y.; Serino, R.; Ozaki, Y.; Saito, J.; Nagata, S.; Yamashita, H. Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats. Regul. Pept. 2002, 104(1-3), 145-51.
91. Horvath, T.L.; Diano, S.; van, den, Pol, AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 1999, 19(3), 1072-87.
92. Yamanaka, A.; Kunii, K.; Nambu, T.; Tsujino, N.; Sakai, A.; Matsuzaki, I.; Miwa, Y.; Goto, K.; Sakurai, T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000 24, 859(2), 404-9.
93. Schioth, H.B.; Muceniece, R.; Wikberg, JE. Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacol. Toxicol. 1996, 79(3), 161-5.
94. Abbott, C.R.; Rossi, M.; Kim, M.; AlAhmed, S.H.; Taylor, G.M.; Ghatei, M.A.; Smith, D.M.; Bloom, S.R. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor. Brain Res. 2000 30, 869(1-2), 203-10.
95. Harrold, J.A.; Widdowson, P.S.; Williams, G. beta-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R? Peptides 2003, 24(3), 397-405.
96. Hsiung, H.M.; Smiley, D.L.; Zhang, X.Y.; Zhang, L.; Yan, L.Z.; Craft, L.; Heiman, M.L.; Smith, D.P. Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human beta-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV. Peptides 2005, 26(10), 1988-96.
97. Challis, B.G.; Pritchard, L.E.; Creemers, J.W.; Delplanque, J.; Keogh, J.M.; Luan, J.; Wareham, N.J.; Yeo, G.S.; Bhattacharyya, S.; Froguel, P.; White, A.; Farooqi, I.S.; O'Rahilly, S. A missense mutation disrupting a dibasic prohormone processing site in proopiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum. Mol. Genet. 2002, 11(17), 1997-2004.
98. Echwald, S.M.; Sorensen, T.I.; Andersen, T.; Tybjaerg-Hansen, A.; Clausen, J.O.; Pedersen, O. Mutational analysis of the proopiomelanocortin gene in Caucasians with early onset obesity. Int. J. Obes. Relat. Metab. Disord. 1999, 23(3), 293-8.
99. Biebermann, H.; Castaneda, T.R.; van, Landeghem, F.; von, Deimling, A.; Escher, F.; Brabant, G.; Hebebrand, J.; Hinney, A.; Tschop, M.H.; Gruters, A.; Krude, H. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006, 3(2), 141-6.
100. Lee, Y.S.; Challis, B.G.; Thompson, D.A.; Yeo, G.S.; Keogh, J.M.; Madonna, M.E.; Wraight, V.; Sims, M.; Vatin, V.; Meyre, D.; Shield, J.; Burren, C.; Ibrahim, Z.; Cheetham, T.; Swift P.; Blackwood, A.; Hung, C.C.; Wareham, N.J.; Froguel, P.; Millhauser, G.L.; O'Rahilly, S.; Farooqi, I.S. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006, 3(2), 135-40.
101. Bloch, B.; Bugnon, C.; Fellmann, D.; Lenys, D.; Gouget, A. Neurons of the rat hypothalamus reactive with antisera against endorphins, ACTH, MSH and beta-LPH. Cell Tissue Res. 1979, 204(1), 1-15.
102. Kishi, T.; Aschkenasi, C.J.; Lee, C.E.; Mountjoy, K.G.; Saper, C.B.; Elmquist, J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J. Comp. Neurol. 2003, 457(3), 213-35.
103. Liu, H.; Kishi, T.; Roseberry, A.G.; Cai, X.; Lee, C.E.; Montez, J.M.; Friedman, J.M.; Elmquist, J.K. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J. Neurosci. 2003, 23(18), 7143-54.
104. Mountjoy, K.G.; Mortrud, M.T.; Low, M.J.; Simerly, R.B.; Cone, R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 1994, 8(10), 1298-308.
105. Kask, A.; Rago, L.; Wikberg, J.E.; Schioth, H.B. Differential effects of melanocortin peptides on ingestive behaviour in rats: evidence against the involvement of MC(3) receptor in the regulation of food intake. Neurosci. Lett. 2000, 283(1), 1-4.
106. Harrold, J.A.; Widdowson, P.S.; Williams, G. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. Diabetes 1999, 48(2), 267-71.
107. Roselli-Rehfuss, L.; Mountjoy, K.G.; Robbins, L.S.; Mortrud, M.T.; Low, M.J.; Tatro, J.B.; Entwistle, M.L.; Simerly, R.B.; Cone, R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. USA 1993, 90(19), 8856-60.
108. Cowley, M.A.; Pronchuk, N.; Fan, W.; Dinulescu, D.M.; Colmers, W.F.; Cone, R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 1999, 24(1), 155-63.
109. Giraudo, S.Q.; Billington, C.J.; Levine, A.S. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 1998, 809(2), 302-6.
110. Kask, A.; Schioth, H.B. Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Res. 2000, 887(2), 460-4.
111. Balthasar, N.; Dalgaard, L.T.; Lee, C.E.; Yu, J.; Funahashi, H.; Williams, T.; Ferreira, M.; Tang, V.; McGovern, R.A.; Kenny, C.D.; Christiansen, L.M.; Edelstein, E.; Choi, B.; Boss, O.; Aschkenasi, C.; Zhang, C.Y.; Mountjoy, K.; Kishi, T.; Elmquist, J.K.; Lowell, B.B. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123(3), 493-505.
112. Kublaoui, B.M.; Holder, J.L, Jr.; Tolson, K.P.; Gemelli, T.; Zinn, A.R. SIM1 overexpression partially rescues agouti yellow and diet-induced obesity by normalizing food intake. Endocrinology 2006, 147(10), 4542-9.
113. Kublaoui, B.M.; Holder, J.L, Jr.; Gemelli, T.; Zinn, A.R. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Mol. Endocrinol. 2006, 20(10), 2483-92.
114. Thiele, T.E.; van, Dijk, G.; Yagaloff, K.A.; Fisher, S.L.; Schwartz, M.; Burn, P.; Seeley, R.J. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am. J. Physiol. 1998, 274(1 2), 248-54.
115. Grill, H.J.; Ginsberg, A.B.; Seeley, R.J.; Kaplan, J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding-and body weight. J. Neurosci. 1998, 18(23), 10128-35.
116. Williams, D.L.; Kaplan, J.M.; Grill, H.J. The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology 2000, 141(4), 1332-7.
117. Lyons, W.E.; Mamounas, L.A.; Ricaurte, G.A.; Coppola, V.; Reid, S.W.; Bora, S.H.; Wihler, C.; Koliatsos, V.E.; Tessarollo, L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. USA 1999, 96(26), 15239-44.
118. Rios, M.; Fan, G.; Fekete, C.; Kelly, J.; Bates, B.; Kuehn, R.; Lechan, R.M.; Jaenisch, R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 2001, 15(10), 1748-57.
119. Xu, B.; Goulding, E.H.; Zang, K., Cepoi, D.; Cone, R.D.; Jones, K.R.; Tecott, L.H.; Reichardt, L.F. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 2003, 6(7), 736-42.
120. Yeo, G.S.; Connie, Hung, C.C.; Rochford, J.; Keogh, J.; Gray, J.; Sivaramakrishnan, S.; O'Rahilly, S.; Farooqi, I.S. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 2004, 7(11), 1187-9.
121. Nakagawa, T.; Tsuchida, A.; Itakura, Y.; Nonomura, T.; Ono, M.; Hirota, F.; Inoue, T.; Nakayama, C.; Taiji, M.; Noguchi, H. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49(3), 436-44.
122. Nonomura, T.; Tsuchida, A.; Ono-Kishino, M.; Nakagawa, T.; Taiji, M.; Noguchi, H. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice. Int. J. Exp. Diabetes Res. 2001, 2(3), 201-9.
123. Pelleymounter, M.A.; Cullen, M.J.; Wellman, C.L. Characteristics of BDNF-induced weight loss. Exp. Neurol. 1995, 131(2), 229-38.
124. Tsuchida, A.; Nonomura, T.; Ono-Kishino, M.; Nakagawa, T.; Taiji, M.; Noguchi, H. Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice. Int. J. Obes. Relat. Metab. Disord. 2001, 25(9), 1286-93.
125. Youngstrom, T.G.; Bartness, T.J. Catecholaminergic innervation of white adipose tissue in Siberian hamsters. Am. J. Physiol. 1995, 268(3pt2), 744-51.
126. Song, C.K.; Jackson, R.M.; Harris, R.B.; Richard, D.; Bartness, TJ. Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289(5), 1467-76.
127. Haynes, W.G.; Morgan, D.A.; Djalali, A.; Sivitz, W.I.; Mark, A.L. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999, 33(1 2), 542-7.
128. Murphy, B.; Nunes, C.N.; Ronan, J.J.; Hanaway, M.; Fairhurst, A.M.; Mellin, T.N. Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J. Appl. Physiol. 2000, 89(1), 273-82.
129. Yasuda, T.; Masaki, T.; Kakuma, T.; Yoshimatsu, H. Hypothalamic melanocortin system regulates sympathetic nerve activity in brown adipose tissue. Exp. Biol. Med. (Maywood) 2004, 229(3), 235-9.
130. Cettour-Rose, P.; Rohner-Jeanrenaud, F. The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 2002, 143(6), 2277-83.
131. Li, G.; Zhang, Y.; Wilsey, J.T.; Scarpace, P.J. Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression. J. Endocrinol. 2004, 182(1), 123-32.
132. Williams, D.L.; Bowers, R.R.; Bartness, T.J.; Kaplan, J.M.; Grill, H.J. Brainstem melanocortin 3/4 receptor stimulation increases uncoupling protein gene expression in brown fat. Endocrinology 2003, 144(11), 4692-7.
133. Lechan, R.M.; Toni, R. Thyrotropin-releasing hormone neuronal systems in the central nervous system. In: Nemeroff CS (ed) NeuroEndocrinology 1992; pp. 279-330
134. Fekete, C.; Legradi, G.; Mihaly, E.; Huang, Q.H.; Tatro, J.B.; Rand, W.M.; Emerson, C.H.; Lechan, R.M. alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J. Neurosci. 2000, 20(4), 1550-8.
135. Harris, M., Aschkenasi, C.; Elias, C.F.; Chandrankunnel, A.; Nillni, E.A.; Bjoorbaek, C.; Elmquist, J.K.; Flier, J.S.; Hollenberg, A.N. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J. Clin. Invest. 2001, 107(1), 111-20.
136. Kim, M.S.; Small, C.J.; Stanley, S.A.; Morgan, D.G.; Seal, L.J.; Kong, W.M.; Edwards, C.M.; Abusnana, S.; Sunter, D.; Ghatei, M.A.; Bloom, S.R. The central melanocortin system affects the hypothalamo-pituitaly thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 2000, 105(7), 1005-11.
137. Kim, M.S.; Small, C.J.; Russell, S.H.; Morgan, D.G.; Abbott, C.R.; alAhmed, S.H.; Hay, D.L.; Ghatei, M.A.; Smith, D.M.; Bloom, S.R. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors. J. Neuroendocrinol. 2002, 14(4), 276-82.
138. Millington, G.W.; Tung, Y.C.; Hewson, A.K.; O'Rahilly, S.; Dickson, S.L. Differential effects of alpha-, beta- and gamma(2)- melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat. Neuroscience 2001, 108(3), 437-45.
139. Fan, W.; Boston, B.A.; Kesterson, R.A.; Hruby, V.J.; Cone, R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385(6612), 165-8.
140. Trivedi, P.; Jiang, M.; Tamvakopoulos, C.C.; Shen, X.; Yu, H.; Mock, S.; Fenyk-Melody, J.; Van, der, Ploeg, L.H.; Guan, X.M. Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Res. 2003, 977(2), 221-30.
141. Kastin, A.J.; Redding, T.W.; Hall, R.; Besser, G.M.; Schally, A.V. Lipid mobilizing hormones of the hypothalamus and pituitary. Pharmacol. Biochem. Behav. 1975, 3(1), 121-6.
142. Forbes, S.; Bui, S.; Robinson, B.R.; Hochgeschwender, U.; Brennan, M.B. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc. Natl. Acad. Sci. USA 2001, 98(7), 4233-7.
143. Bluher, S.; Ziotopoulou, M.; Bullen, J.W, Jr.; Moschos, S.J.; Ungsunan, L.; Kokkotou, E.; Maratos-Flier, E.; Mantzoros, C.S. Responsiveness to peripherally administered melanocortins in lean and obese mice. Diabetes 2004, 53(1), 82-90.
144. Hansen, M.J.; Ball, M.J.; Morris, M.J. Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res. 2001, 892(1), 130-7.
145. Hansen, M.J.; Schioth, H.B.; Morris, M.J. Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Brain Res. 2005, 1039(1-2), 137-45.
146. Hwa, J.J.; Ghibaudi, L.; Gao, J.; Parker, E.M. Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281(2), 444-51.
147. Kim, E.M.; O'Hare, E.; Grace, M.K.; Welch, C.C.; Billington, C.J.; Levine, A.S. ARC POMC mRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats. Brain Res. 2000, 862(1-2), 11-6.
148. Lin, S.; Storlien, L.H.; Huang, X.F. Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res. 2000, 875(1-2), 89-95.
149. Clegg, D.J.; Benoit, S.C.; Air, E.L.; Jackman, A.; Tso, P.; D'Alessio, D.; Woods, S.C.; Seeley, R.J. Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII. Endocrinology 2003, 144(7), 2941-6.
150. McMinn, J.E.; Wilkinson, C.W.; Havel, P.J.; Woods, S.C.; Schwartz, M.W. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279(2), 695-703.
151. Benoit, S.C.; Schwartz, M.W.; Lachey, J.L.; Hagan, M.M.; Rushing, P.A.; Blake, K.A.; Yagaloff, K.A.; Kurylko, G.; Franco, L.; Danhoo, W.; Seeley, R.J. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J. Neurosci. 2000, 20(9), 3442-8.
152. Hsiung, H.M.; Hertel, J.; Zhang, X.Y.; Smith, D.P.; Smiley, D.L.; Heiman, M.L.; Yang, D.D.; Husain, S.; Mayer, J.P.; Zhang, L.; Mo, H.; Yan, L.Z. A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats. Endocrinology 2005, 146(12), 5257-66.
153. Azzara, A.V.; Sokolnicki J.P.; Schwartz, G.J. Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition. Physiol. Behav. 2002, 77(2-3), 411-6.
154. Williams, D.L.; Grill, H.J.; Weiss, S.M.; Baird, J.P.; Kaplan, J.M. Behavioral processes underlying the intake suppressive effects of melanocortin 3/4 receptor activation in the rat. Psychopharmacology (Berl) 2002, 161(1), 47-53.
155. Jonsson, L.; Skarphedinsson, J.O.; Skuladottir, G.V.; Atlason, P.T.; Eiriksdottir, V.H.; Franzson, L.; Schioth, H.B. Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport. 2001, 12(17), 3703-8.
156. Mayer, J.P.; Hsiung, H.M., Flora, D.B.; Edwards, P.; Smith, D.P.; Zhang, X.Y.; Gadski, R.A.; Heiman, M.L.; Hertel, J.L.; Emmerson, P.J.; Husain, S.; O'brien, T.P.; Kahl, S.D.; Smiley, D.L.; Zhang, L.; Dimarchi, R.D.; Yan, L.Z. Discovery of a beta-MSH-derived MC-4R selective agonist. J. Med. Chem. 2005, 48(9), 3095-8.
157. Pierroz, D.D.; Ziotopoulou, M.; Ungsunan, L.; Moschos, S.; Flier, J.S.; Mantzoros, C.S. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 2002, 51(5), 1337-45.
158. Jonsson, L.; Skarphedinsson, J.O.; Skuladottir, G.V.; Watanobe, H.; Schioth, HB. Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J. Endocrinol. 2002, 173(3), 517-23.
159. Raposinho, P.D.; White, R.B.; Aubert, M.L. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. J. Neuroendocrinol. 2003, 15(2), 173-81.
160. Hoggard, N.; Rayner, D.V.; Johnston, S.L.; Speakman, JR. Peripherally administered Nle4D-Phe7]-alpha-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice. J. Mol. Endocrinol. 2004, 33(3), 693-703.
161. Hamilton, B.S.; Doods, H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes. Res. 2002, 10(3), 182-7.
162. Kask, A.; Rago, L.; Mutulis, F.; Pahkla, R.; Wikberg, J.E.; Schioth, H.B. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem. Biophys. Res. Commun. 1998 245(1), 90-3.
163. Kask, A.; Mutulis, F.; Muceniece, R.; Pahkla, R.; Mutule, I.; Wikberg, J.E.; Rago, L.; Schioth, H.B. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology 1998, 139(12), 5006-14.
164. Skuladottir, G.V.; Jonsson, L.; Skarphedinsson, J.O.; Mutulis, F.; Muceniece, R.; Raine, A.; Mutule, I.; Helgason, J.; Prusis, P.; Wikberg, J.E.; Schioth, H.B. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br. J. Pharmacol, 1999, 126(1), 27-34.
165. Johnson, P.D.; Dawson, B.V.; Dorr, R.T.; Hadley, M.E.; Levine, N.; Hruby, V.J. Coat color darkening in a dog in response to a potent melanotropic peptide. Am. J. Vet. Res. 1994, 55(11), 1593-6.
166. Vemulapalli, R.; Kurowski, S.; Salisbury, B.; Parker, E.; Davis, H. Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO. Br. J. Pharmacol. 2001, 134(8), 1705-10.
167. Martin, W.J.; McGowan, E.; Cashen, D.E.; Gantert, L.T.; Drisko, J.E.; Hom, G.J.; Nargund, R.; Sebhat, I; Howard, A.D.; Van, der, Ploeg, L.H.; MacIntyre, D.E. Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula. Eur. J. Pharmacol. 2002, 454(1), 71-9.
168. Van, der, Ploeg, L.H.; Martin, W.J.; Howard, A.D.; Nargund, R.P.; Austin, C.P.; Guan, X.; Drisko, J.; Cashen, D.; Sebhat, I.; Patchett, A.A.; Figueroa, D.J.; DiLella, A.G.; Connolly, B.M.; Weinberg, D.H.; Tan, C.P.; Palyha, O.C.; Pong, S.S.; MacNeil, T.; Rosenblum, C.; Vongs, A.; Tang, R.; Yu, H.; Sailer, A.W.; Fong, T.M.; Huang, C.; Tota, M.R.; Chang, R.S.; Steams, R.; Tamvakopoulos, C.; Christ, G.; Drazen, D.L.; Spar, B.D.; Nelson, R.J.; MacIntyre, D.E. A role for the melanocortin 4 receptor in sexual function. Proc. Natl. Acad. Sci. USA 2002, 99(17), 11381-6.
169. McKenna, K.E. Some proposals regarding the organization of the central nervous system control of penile erection. Neurosci. Biobehav. Rev. 2000, 24(5), 535-40.
170. Molinoff, P.B.; Shadiack, A.M.; Earle, D.; Diamond, L.E.; Quon, CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann. N. Y. Acad. Sci. 2003, 994, 96-102.
171. Wessells, H.; Hruby, V.J.; Hackett, J.; Han, G.; Balse-Srinivasan, P.; Vanderah, TW. Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors. Nouroscience 2003, 118(3), 755-62.
172. Pfaus, J.G.; Shadiack, A.; Van, Soest, T.; Tse, M.; Molinoff, P. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc. Natl. Acad. Sci. USA 2004, 101(27), 10201-4.
173. Cragnolini, A.; Scimonelli, T.; Celis, M.E.; Schioth, H.B. The role of melanocortin receptors in sexual behavior in female rats. Neuropeptides 2000, 34(3-4), 211-5.
174. Fehm, H.L.; Smolnik, R.; Kern, W.; McGregor, G.P.; Bickel, U.; Born, J. The melanocortin melanocyte-stimulating hormone/ adrenocorticotropin(4-10) decreases body fat in humans. J. Clin. Endocrinol. Metab. 2001, 86(3), 1144-8.
175. Hallschmid, M.; Smolnik, R.; McGregor, G.; Born, J.; Fehm, H.L. Overweight humans are resistant to the weight-reducing effects of melanocortin4-10. J. Clin. Endocrinol. Metab. 2006, 91(2), 522-5.
176. Smolnik, R.; Molle, M.; Fehm, H.L.; Born, J. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans. Neuroendocrinology 1999, 70(1), 63-72.
177. Krude, H.; Biebermann, H.; Schnabel, D.; Tansek, M.Z.; Theunissen, P.; Mullis, P.E.; Gruters, A. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J. Clin. Endocrinol. Metab. 2003, 88(10), 4633-40.
178. Dorr, R.T.; Lines, R.; Levine, N.; Brooks, C.; Xiang, L.; Hruby, V.J.; Hadley, M.E. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996, 58(20), 1777-84.
179. Wessells, H.; Fuciarelli, K.; Hansen, J.; Hadley, M.E.; Hruby, V.J.; Dorr, R.; Levine, N. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol. 1998, 160(2), 389-93.
180. Wessells, H.; Gralnek, D.; Dorr, R.; Hruby, V.J.; Hadley, M.E.; Levine, N. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 2000, 56(4), 641-6.
181. Diamond, L.E.; Earle, D.C.; Heiman, J.R.; Rosen, R.C.; Perelman, MA.; Harning, R. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. J. Sex Med. 2006, 3(4), 628-38.
182. Sawyer, T.K.; Sanfilippo, P.J.; Hruby, V.J.; Engel, M.H.; Heward, C.B.; Burnett, J.B.; Hadley, M.E. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA 1980, 77(10), 5754-8.
183. Al-Obeidi, F.; Hadley, M.E.; Pettitt, M.B.; Hruby, V.J. Design of a new class of superpotent cyclic a-melanotropins based on quenched dynamic simulations. J. Am. Chem. Soc. 1989, 111, 3413-3416.
184. Schioth, H.B.; Muceniece, R.; Mutulis, F.; Prusis, P.; Lindeberg, G.; Sharma, S.D.; Hruby, V.J.; Wikberg, J.E. Selectivity of cyclic [D-Na17] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides 1997, 18(7), 1009-13.
185. Kavarana, M.J.; Trivedi, D.; Cai, M.; Ying, J.; Hammer, M.; Cabello, C.; Grieco, P.; Han, G.; Hruby, V.J. Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. J. Med. Chem. 2002, 45(12), 2644-50.
186. Sawyer, T.K.; Hruby, V.J.; Darman, P.S.; Hadley, M.E. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity. Proc. Natl. Acad. Sci. USA 1982, 79(6), 1751-5.
187. Hruby, V.J.; Lu, D.; Sharma, S.D.; Castrucci, A.L.; Kesterson, R.A.; al-Obeidi, F.A.; Hadley, M.E.; Cone, R.D. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 1995, 38(18), 3454-61.
188. Oosterom, J.; Nijenhuis, W.A.; Schaaper, W.M.; Slootstra, J.; Meloen, R.H.; Gispen, W.H.; Burbach, J.P.; Adan, R.A. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors. J. Biol. Chem. 1999, 274(24), 16853-60.
189. Nargund, R.P.; Strack, A.M.; Fong, T.M. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. J. Med. Chem. 2006, 49(14), 4035-43.
190. Fotsch, C.; Han, N.; Arasasingham, P.; Bo, Y.; Carmouche, M.; Chen, N.; Davis, J.; Goldberg, M.H.; Hale, C.; Hsieh, F.Y.; Kelly, M.G.; Liu, Q.; Norman, M.H.; Smith, D.M.; Stec, M.; Tamayo, N.; Xi, N.; Xu, S.; Bannon, A.W.; Baumgartner, J.W. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15(6), 1623-7.
191. Pan, K.; Scott, M.K.; Lee, D.H.; Fitzpatrick, L.J.; Crooke, J.J.; Rivero, R.A.; Rosenthal, D.I.; Vaidya, A.H.; Zhao, B.; Reitz, A.B. 2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in rats. Bioorg. Med. Chem. 2003, 11(2), 185-92.
192. Ujjainwalla, F.; Warner, D.; Walsh, T.F.; Wyvratt, M.J.; Zhou, C.; Yang, L.; Kalyani, R.N.; MacNeil, T.; Van, der, Ploeg, L.H.; Rosenblum, C.I.; Tang, R.; Vongs, A.; Weinberg, D.H.; Goulet, M.T. Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetype. Bioorg. Med. Chem. Lett. 2003, 13(24), 4431-5.
193. Verty, A.N.; McFarlane, J.R.; McGregor, I.S.; Mallet, P.E. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology 2004, 145(7), 3224-31.
194. Balse-Srinivasan, P.; Grieco, P.; Cai, M.; Trivedi, D.; Hruby, V.J. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues. J. Med. Chem. 2003, 46, 4965-73.
195. Yan, L.Z.; Flora, D.; Edwards, P.; Smiley, D.L.; Emmerson, P.J.; Hsiung, H.M.; Gadski R.; Hertel, J.; Heiman, M.L.; Husain, S.; O'Brien, T.P.; Kahl, S.D.; Zhang, L.; Dimarchi, R.D.; Mayer, J.P. Potent and selective MC-4 receptor agonists based on a novel disulfide scaffold. Bioorg. Med. Chem. Lett. 2005, 15, 4611-4.
196. Shi, Q.; Ornstein, P.L.; Briner, K.; Richardson, T.I.; Arnold, M.B.; Backer, R.T.; Buckmaster, J.L.; Canada, E.J.; Doecke, C.W.; Hertel, L.W.; Honigschmidt, N.; Hsiung, H.M.; Husain, S.; Kuklish, S.L.; Martinelli, M.J.; Mullaney, J.T.; O'Brien, T.P.; Reinhard, M.R.; Rothhaar, R.; Shah, J.; Wu, Z.; Xie, C.; Zgombick, J.M.; Fisher, M.J. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor. Bioorg. Med. Chem. Lett. 2006, 16, 2341-6.